Exon Publications publishes high-quality, peer-reviewed books in the fields of health and biomedical sciences. Our books are indexed in NCBI/NIH/NLM Bookshelf, PubMed, Europe PubMed Central and Web of Science. Publish a book chapter. Visit catalogue.
We abide by the Principles of Transparency and Best Practice in Scholarly Publishing, and is a member of the International Association of Scientific, Technical and Medical Publishers (STM) and the Association of Learned and Professional Society Publishers (ALPSP).
Our Authors: Researchers from reputed institutions have published with us. The complete list is available here.
The Middle East & Africa
Our Editors: Experts from reputed institutions have edited books for us. The complete list is available here.
Exon Publications, Brisbane, Australia
Waldemar Debinski, MD, PhD (ed)
Brain Tumor Center of Excellence, Wake Forest
Baptist Medical Center Comprehensive Cancer Center, Winston Salem, NC, USA
Gliomas are the primary brain tumors of the central nervous system. The prognosis, especially for high-grade gliomas, is dismal; the treatment of these tumors represents an unmet need in medicine. This book, contributed by an excellent team of clinicians and basic scientists, touches upon several critical aspects of glioma research and clinical therapies. There is a considerable emphasis on translational efforts. The 13 chapters of the book cover aspects of clinically-relevant models, glioma stem-like cells, IDH mutations, integrated approach for better patient outcome, abnormal cholesterol and other metabolic processes, bioinformatics for survival prediction, molecular signature for prognostication, neuro-functional monitoring during surgery, glioma-related epilepsy, and glioneuronal tumors along with various natural and synthetic drug candidates currently under evaluation. As such, the individual contributions provide a glimpse on the magnitude of challenges and potential solutions in a variety of research areas. This book will likely be interest to a wide audience seeking more information on challenges gliomas present to both scientists and clinicians.